ProPhase Labs Inc Capital Reinvestment Ratio

Latest as of March 2023: 1.09x

ProPhase Labs Inc capital reinvestment ratio. ProPhase Labs Inc (PRPH) has a Capital Reinvestment Ratio of 1.09x as of March 2023, meaning it reinvests 1% of its operating cash flow ($476.00K) in capital expenditures ($517.00K). See ProPhase Labs Inc (PRPH) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

1.09x
Capex / Operating Cash Flow

Operating Cash Flow

$476.00K
USD

Capital Expenditures

$517.00K
USD

Data as of

Mar 2023
Most recent filing

Capital Reinvestment Ratio of ProPhase Labs Inc (1997–2022)

Capital reinvestment ratio of ProPhase Labs Inc from 1997 to 2022. This chart tracks ProPhase Labs Inc's Capital Reinvestment Ratio across 10 annual periods. See how financially flexible is ProPhase Labs Inc to measure the company's free cash flow as a share of total liabilities.

ProPhase Labs Inc Capital Reinvestment Ratio by Year (1997–2022)

ProPhase Labs Inc capital reinvestment ratio by year from 1997 to 2022. For the full cash flow conversion analysis, see how efficiently does ProPhase Labs Inc generate cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2022 0.14x $28.55 Million $3.92 Million ▼ -64.7%
2013 0.39x $1.14 Million $442.00K ▼ -16.8%
2009 0.47x $445.00K $208.00K ▼ -35.9%
2006 0.73x $956.94K $697.48K ▲ +485.3%
2005 0.12x $4.27 Million $531.21K ▲ +87.1%
2004 0.07x $4.66 Million $310.14K ▼ -93.8%
2002 1.07x $543.64K $580.86K ▲ +38.9%
1999 0.77x $1.30 Million $1.00 Million ▲ +584.6%
1998 0.11x $8.90 Million $1.00 Million ▲ +911.2%
1997 0.01x $9.00 Million $100.00K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow